Sunnybrook Health Sciences Centre, commonly known as Sunnybrook Hospital or simply Sunnybrook, is an academic health science centre located in Toronto, Ontario, Canada. It is the largest trauma centre in Canada and one of two trauma centres in Toronto; the other being St. Michael's Hospital.

There are 1,325 (including bassinet beds) beds in Women's College Campus, Sunnybrook and Women's College Health Science Center.

During the past decade, Women's College Campus, Sunnybrook and Women's College Health Science Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Women's College Campus, Sunnybrook and Women's College Health Science Center" #1 sponsor was "NCIC Clinical Trials Group" with 6 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Dendreon" with 2 trials sponsored, "Knopp Biosciences" with 2 trials sponsored and "AGO Study Group" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Women's College Campus, Sunnybrook and Women's College Health Science Center" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Women's College Campus, Sunnybrook and Women's College Health Science Center" are "Amyotrophic Lateral Sclerosis" (2 trials), "Breast Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Colorectal Cancer" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Women's College Campus, Sunnybrook and Women's College Health Science Center" in a lesser frequency.

Most popular intervention types in "Women's College Campus, Sunnybrook and Women's College Health Science Center" are "Drug" (12 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexpramipexole" (2 trials), "alvocidib" (2 trials), "APC-Placebo" (1 trials), "APC8015F" (1 trials) and "CT Scan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Women's College Campus, Sunnybrook and Women's College Health Science Center" are 11 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Women's College Campus, Sunnybrook and Women's College Health Science Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Women's College Campus, Sunnybrook and Women's College Health Science Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Women's College Campus, Sunnybrook and Women's College Health Science Center, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".